These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12702519)

  • 21. Docetaxel in anthracycline-resistant metastatic breast cancer.
    Hui YF; Ignoffo RJ
    Cancer Pract; 1997; 5(2):124-7. PubMed ID: 9110651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case report: effective trans-arterial neoadjuvant chemotherapy with docetaxel for a local advanced breast cancer patient].
    Sakita I; Tamaki Y; Miyazaki M; Kadota M; Masuda N; Ooka M; Ohue M; Sekimoto M; Tomita N; Monden M
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1955-8. PubMed ID: 10560435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?
    Nabholtz JM; Tonkin K; Smylie M; Au HJ; Lindsay MA; Mackey J
    Expert Opin Pharmacother; 2000 Jan; 1(2):187-206. PubMed ID: 11249542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risks and benefits of taxanes in breast and ovarian cancer.
    Michaud LB; Valero V; Hortobagyi G
    Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docetaxel (Taxotere) for advanced breast cancer.
    Med Lett Drugs Ther; 1996 Sep; 38(984):87-8. PubMed ID: 8828520
    [No Abstract]   [Full Text] [Related]  

  • 26. Reflections on the development of resistance during therapy for advanced breast cancer. Implications of high levels of activity of docetaxel in anthracycline-resistant breast cancer patients.
    Ravdin PM
    Eur J Cancer; 1997 Aug; 33 Suppl 7():S7-10. PubMed ID: 9486096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Taxing the taxanes: overused or undersold?
    Miller M
    J Natl Cancer Inst; 1999 Dec; 91(24):2077-8. PubMed ID: 10601377
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of taxanes in adjuvant therapy.
    Münster PN; Hudis CA
    Cancer Invest; 2000; 18(1):32-8. PubMed ID: 10701365
    [No Abstract]   [Full Text] [Related]  

  • 29. Taxanes in adjuvant and neoadjuvant therapies for breast cancer.
    O'Leary J; Volm M; Wasserheit C; Muggia F
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):23-7. PubMed ID: 9516599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taxoids.
    Kaye SB
    Eur J Cancer; 1995; 31A(5):824-6. PubMed ID: 7640068
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of taxanes in treatment of breast cancer].
    Gorbunova VA; Besova NS
    Vopr Onkol; 2004; 50(4):492-500. PubMed ID: 15605777
    [No Abstract]   [Full Text] [Related]  

  • 32. Taxoids in combination chemotherapy for metastatic breast cancer.
    Dieras V; Fumoleau P; Bourgeois H; Misset JL; Azli N; Pouillart P
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():47-52. PubMed ID: 8862712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docetaxel. A review of its role in breast cancer treatment.
    Antoine EC; Rixe O; Auclerc G; Weil M; Khayat D
    Am J Clin Oncol; 1997 Aug; 20(4):429-32. PubMed ID: 9256905
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of taxanes in the combined modality treatment of patients with locally advanced non-small cell lung cancer.
    Choy H; Pyo H; Kim JS; MacRae R
    Expert Opin Pharmacother; 2001 Jun; 2(6):963-74. PubMed ID: 11585012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical rationale for developing docetaxel (Taxotere).
    Armand JP
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():37-9. PubMed ID: 8862710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging role of docetaxel (Taxotere) in the adjuvant therapy of breast cancer.
    Ravdin PM
    Semin Oncol; 1999 Jun; 26(3 Suppl 9):20-3. PubMed ID: 10426455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer.
    Chappuis PO; Goffin J; Wong N; Perret C; Ghadirian P; Tonin PN; Foulkes WD
    J Med Genet; 2002 Aug; 39(8):608-10. PubMed ID: 12161606
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of taxanes in lung-cancer chemotherapy.
    Schiller JH
    Cancer Invest; 1998; 16(7):471-7. PubMed ID: 9774954
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost-utility analysis of chemotherapy using paclitaxel, docetaxel, or vinorelbine for patients with anthracycline-resistant breast cancer.
    Leung PP; Tannock IF; Oza AM; Puodziunas A; Dranitsaris G
    J Clin Oncol; 1999 Oct; 17(10):3082-90. PubMed ID: 10506603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [From conquering metastatic disease to adjuvant therapy: clinical evolution of docetaxel in breast cancer].
    Cartenì G
    Tumori; 2001; 87(6):A1-5. PubMed ID: 11995695
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.